Update on Therapeutics for Diabetes and Catabolic Disorders: Pt. 4: Capromorelin and GHRH Plasmid Rx

This is Part 4 of a presentation by Duncan C. Ferguson, VMD, PhD, DACVIM, DACVCP on February 12, 2026 about new endocrine therapeutics as part of the American College of Veterinary Clinical Pharmacology (ACVCP)/European College of Veterinary Pharmacology and Toxicology (ECVPT) residency training seminar series. This part focuses on capromorelin for treatment of anorexia and GHRH plasmid therapy for cachexia and immunosenescence of aging.. Presented by ACVCP, ECVPT and VetMedAcademy.org. For additional videos on this topic and learning materials, please register with VetMedAcademy at https://vetmedacademy.org